Payden & Rygel’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-99,900
Closed -$6.28M 128
2024
Q3
$6.28M Buy
+99,900
New +$6.28M 0.48% 69
2024
Q2
Sell
-183,500
Closed -$14.6M 127
2024
Q1
$14.6M Sell
183,500
-135,500
-42% -$10.8M 0.69% 55
2023
Q4
$25.2M Buy
319,000
+35,600
+13% +$2.81M 1.75% 9
2023
Q3
$19.8M Buy
283,400
+182,000
+179% +$12.7M 1.35% 15
2023
Q2
$7.01M Buy
101,400
+97,300
+2,373% +$6.73M 0.5% 80
2023
Q1
$305K Sell
4,100
-432,100
-99% -$32.1M 0.02% 109
2022
Q4
$40.6M Buy
436,200
+29,000
+7% +$2.7M 2.17% 8
2022
Q3
$38.8M Buy
407,200
+8,700
+2% +$830K 2.27% 3
2022
Q2
$36.9M Buy
398,500
+821
+0.2% +$76.1K 2.22% 8
2022
Q1
$40.2M Sell
397,679
-114,700
-22% -$11.6M 2.03% 10
2021
Q4
$52.9M Sell
512,379
-2,200
-0.4% -$227K 2.44% 1
2021
Q3
$43.7M Buy
514,579
+235,300
+84% +$20M 2.27% 4
2021
Q2
$23.3M Sell
279,279
-147,837
-35% -$12.3M 1.11% 47
2021
Q1
$32.1M Buy
427,116
+16,716
+4% +$1.26M 1.49% 27
2020
Q4
$28M Buy
410,400
+128,100
+45% +$8.75M 1.44% 35
2020
Q3
$16.5M Sell
282,300
-76,600
-21% -$4.47M 0.98% 58
2020
Q2
$23.3M Sell
358,900
-1,100
-0.3% -$71.5K 1.49% 32
2020
Q1
$21.4M Buy
360,000
+15,271
+4% +$906K 1.54% 31
2019
Q4
$25.6M Sell
344,729
-250,200
-42% -$18.6M 1.6% 33
2019
Q3
$37.5M Buy
594,929
+108,129
+22% +$6.82M 2.55% 5
2019
Q2
$26.5M Buy
486,800
+229,800
+89% +$12.5M 1.82% 20
2019
Q1
$13.9M Buy
+257,000
New +$13.9M 1.01% 52
2016
Q1
Sell
-187
Closed -$18K 171
2015
Q4
$18K Buy
+187
New +$18K ﹤0.01% 143